Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Current Leases: 2022-2024

Historic Current Leases for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $550,000.

  • Orchestra BioMed Holdings' Current Leases rose 76.20% to $696,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $696,000, marking a year-over-year increase of 76.20%. This contributed to the annual value of $550,000 for FY2024, which is 15.25% down from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Current Leases is $550,000, which was down 15.25% from $649,000 recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Current Leases registered a high of $697,000 during FY2022, and its lowest value of $550,000 during FY2024.
  • For the 3-year period, Orchestra BioMed Holdings' Current Leases averaged around $632,000, with its median value being $649,000 (2023).
  • Data for Orchestra BioMed Holdings' Current Leases shows a maximum YoY declined of 15.25% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Current Leases stood at $697,000 in 2022, then decreased by 6.89% to $649,000 in 2023, then decreased by 15.25% to $550,000 in 2024.